Serum anti-müllerian hormone levels in evaluation of chemotherapy effect on ovarian reserve in women with breast cancer

This publication has 20 references indexed in Scilit:

• Antral Follicles Count and Anti-Müllerian Hormone Levels after Gonadotoxic Chemotherapy in Patients with Breast Cancer: Cohort Study
  Revista Brasileira de Ginecologia e Obstetrícia, 2017
• Anti-müllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy
  European Journal of Cancer, 2017
• Anti-Mullerian Hormone:Above and Beyond Conventional Ovarian Reserve Markers
  Disease Markers, 2016
• Anti-Müllerian hormone: determination of ovarian reserve in early breast cancer patients
  Endocrine-Related Cancer, 2013
• Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer
  European Journal of Cancer, 2013
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
  International Journal of Cancer, 2010
• Relationship of Serum Antimüllerian Hormone Concentration to Age at Menopause
  The Journal of Clinical Endocrinology & Metabolism, 2008
• Web-Based Survey of Fertility Issues in Young Women With Breast Cancer
  Journal of Clinical Oncology, 2004
• Cancer Statistics, 2004
  CA: A Cancer Journal for Clinicians, 2004
• Does Measurement of Inhibin Have a Clinical Role?
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2000